Phibro Animal Health Corp - Class A

PAHC NASDAQ Healthcare & Biotech Monde US71742Q1067
31.64 $
3.64 %

Phibro Animal Health Corp focuses on the development and marketing of animal health products, including pharmaceuticals and nutritional supplements.

Performance & Momentum

6 Months 20.53 %
1 Year 32.25 %
3 Years 144.72 %
5 Years 20.11 %

Strategic Analysis

Phibro Animal Health Corp is positioned in the animal health market by developing and marketing innovative solutions that combine pharmaceuticals and nutritional supplements. Its model incorporates strong biotechnology expertise, enabling it to target sustained growth in the agrifood sector by improving livestock productivity and health.

Strengths
  • Deep expertise in biotechnology applied to animal health
  • Positioning in a growing market driven by global protein demand
  • Diversified portfolio combining pharmaceuticals and nutritional supplements
Weaknesses
  • Exposure to regulatory fluctuations specific to animal health
  • Sensitivity to changes in raw material costs related to animal feed
Momentum

Very positive momentum reflects robust commercial performance and renewed investor interest, supported by steady long-term growth. This trend reinforces an investment strategy focused on capturing the structural growth of the animal health market.

Similar stocks to Phibro Animal Health Corp - Class A

Anantys Community

Be the first to share your analysis on Phibro Animal Health Corp - Class A.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases